Clinical Trial Update: A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Orvepitant for pruritus associated with atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Pruritus

Drugs mentioned

• Orvepitant (Orvepitant)

Snippet

Sponsor: Nerre Therapeutics Ltd. | Conditions: Pruritus, Atopic Dermatitis | Phase 2 | Status: WITHDRAWN